These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16868038)

  • 1. Oestroprogestagens and severe acute pyelonephritis: a casual or causal association?
    Piccoli GB; Colla L; Mezza E; Burdese M; Cammarota T; Piccoli G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337. PubMed ID: 16868038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of the oral hormonal contraception].
    Avramova V
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():49-59. PubMed ID: 19504710
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
    Cogliano V; Grosse Y; Baan R; Straif K; Secretan B; El Ghissassi F;
    Lancet Oncol; 2005 Aug; 6(8):552-3. PubMed ID: 16094770
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colpocytological patterns after prolonged treatment with combined estroprogestinic drugs].
    Vernotico V; Zanella B
    Minerva Ginecol; 1975 Jun; 27(6):448-56. PubMed ID: 1153121
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of hormone replacement therapy in the management of premature ovarian failure.
    Christin-Maitre S
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):60-1. PubMed ID: 18030288
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.
    Lawton B; Rose S; McLeod D; Dowell A
    BMJ; 2003 Oct; 327(7419):845-6. PubMed ID: 14551101
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM
    Thromb Res; 2013 Jan; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviews of hormone replacement therapy evidence support findings in recently halted trial.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Sep; 13(17):7-9. PubMed ID: 12572547
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRT 2000: pause for thought.
    Harv Womens Health Watch; 2000 Apr; 7(8):1-3. PubMed ID: 10712769
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary amenorrhea following ovulation inhibitors].
    Kunz J; Keller PJ
    Schweiz Med Wochenschr; 1974 Jun; 104(26):923-7. PubMed ID: 4422939
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal contraception: noncontraceptive benefits and medical contraindications.
    Rager KM; Omar HA
    Adolesc Med Clin; 2005 Oct; 16(3):539-51. PubMed ID: 16183538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contraceptives: update].
    Fugère P
    Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for the therapeutic use of contraceptive steroids].
    Nocke W
    Med Welt; 1975 Aug; 6(35):1509-17. PubMed ID: 1100993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen use in systemic lupus erythematosus].
    Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
    Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
    Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.